Artificial Intelligence

At MWC 2026, TechSee unveiled a platform that lets service providers see inside your home, promising to fix connectivity woes and cut churn.

A Chinese firm's 'Global Pioneer' status in cellular essence sparks debate on the future of biotech in cosmetics, medicine, and global regulation.

Zensai secures its spot as a top European HR tech provider for a second year, leveraging deep AI integration within Microsoft 365 to redefine corporate learning.

At MWC 2026, pureLiFi unveiled a new device to solve 5G's indoor signal woes and demonstrated a staggering 10 Gbps LiFi connection.

HARMAN's new rugged platform brings automotive-grade safety, security, and infotainment to two-wheelers, targeting a market ripe for a tech overhaul.

At the India AI Impact Summit, experts warned that AI crises will move at machine speed. Can global diplomacy and safety protocols catch up before it's too late?

At MWC Barcelona, Qualcomm revealed a massive coalition aiming to build an AI-native 6G network, setting the stage for a new era of intelligent connectivity.

Indian firm Genus Power surpasses 26M smart meter deployments, leveraging its dominant role in national grid reform to expand its footprint worldwide.

At MWC 2026, MaxLinear showcases a single-chip solution enabling smaller, greener 5G radios, tackling key hurdles in the promising Open RAN market.

A new non-equity partnership aims to leverage AI and automation, reshaping the global digital transformation market and enterprise customer experience.

TCL announces its award-winning NXTPAPER 70 Pro is coming to the US, boasting a revolutionary paper-like display designed to combat digital eye strain.

With a new CTO and a bold strategy, Lithuania's Artea Bank aims to challenge giants. Can it become the Apple of Baltic banking?

The telecom industry is uniting to build AI that speaks its language, launching a new open initiative to develop specialized models for complex networks.

Shareholder approval paves the way for cancer therapy innovator VERAXA to go public, aiming to accelerate its next-gen antibody-drug conjugate pipeline.

A new dating app, QingTengZhiLian HK, promises to end swipe fatigue with psychology and AI. But can an algorithm truly engineer love in a crowded market?

In a radical pivot, diagnostics firm OpGen has become CapForce, an AI-powered investment bank targeting a $10B niche. Can it trade microbes for money?

With key investor conferences looming, Asana is set to showcase its AI strategy. Can it convince Wall Street its vision will drive profit and beat rivals?

Biotech firm NurExone showcases its CNS injury platform at key conferences, but the exit of its US subsidiary's CEO casts a shadow on growth plans.

Facing delisting for being a 'public shell,' XTL Biopharma plans an appeal while its new acquisition and valuable IP hang in the balance.

The biotech firm's stock surged after announcing a massive share repurchase, a bold move balancing shareholder value with its high-stakes R&D pipeline.